How big is the bleeding disorder testing market?

The global bleeding disorder testing market size was estimated at USD 6.8 billion in 2022 and is expected to reach USD 7.4 billion in 2023.

What is the bleeding disorder testing market growth?

The global bleeding disorder testing market is expected to grow at a compound annual growth rate of 9.4% from 2022 to 2032 to reach USD 16.3 billion by 2032.

Which are the prominent players in the global bleeding disorder testing market?

Some of the prominent players operating in this market place are F. Hoffmann-La Roche Ltd.(Switzerland), Siemens Healthcare GmbH (Germany), HORIBA Ltd.(Japan), Sysmex Corporation (Japan), Abbott (U.S.), Thermo Fisher Scientific Inc.(U.S.), Johnson and Johnson, Pfizer Inc.

Global Bleeding Disorder Testing Market By Product Type (Reagents, Consumables, and Instruments) By Indication (Hemophilia A, Hemophilia B, and Von Willibrand Disease) By End User (Hospitals and Clinics, Diagnostic centers) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

Published date: Oct 2023
Report ID: 96800
Number of Pages: 236
Format:

Overview
Table of Contents
Major Market Players
Request a Free Sample

- F. Hoffmann-La Roche Ltd. (Switzerland)
- Siemens Healthcare GmbH (Germany)
- HORIBA Ltd. (Japan)
- Sysmex Corporation (Japan)
- Abbott (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Johnson and Johnson
- Pfizer Inc Company Profile
- Other key players

Related Reports

Floor Coatings Market
AI in Food Processing Market
Medical Devices Market
Directed Energy Weapons Market
Advanced Driver Assistance Systems Market
Peptic Ulcer Drugs Market

Our Clients

Report ID 96800
Published Date Oct 2023
Rating
- ★★★★★
  
  ★★★★★
- (50)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible